Oncogenic MYD88 Mutations Are Rare Events in Double-Hit B-Cell Lymphomas | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Oncogenic MYD88 Mutations Are Rare Events in Double-Hit B-Cell Lymphomas

Acta Haematol (2014) 133 (1): 113–115.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

High-Grade B-cell Lymphomas

Anna Shestakova
Kristin H. Karner

Advances in Molecular Pathology (2022) 5 (1): 41.

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome

Jordina Rovira
Kennosuke Karube
Alexandra Valera
Dolors Colomer
Anna Enjuanes
Lluís Colomo
Alejandra Martínez-Trillos
Eva Giné
Ivan Dlouhy
Laura Magnano
Julio Delgado
Antonio Martínez
Neus Villamor
Elías Campo
Armando López-Guillermo

Clinical Cancer Research (2016) 22 (11): 2755.